Reckitt Publishes 2025 Annual Report and Sets Date for 2026 AGM

Reckitt ( (GB:RKT) ) has provided an announcement.

Reckitt Benckiser Group has published its Annual Report and Financial Statements for the year ended 31 December 2025, along with the notice of its 2026 Annual General Meeting, on the company’s website and via the UK National Storage Mechanism. These documents, including the AGM notice and proxy form, will also be mailed or otherwise made available to shareholders ahead of the AGM, which is scheduled to take place on 21 May 2026 at the London Heathrow Marriott Hotel in Hayes.

The release underscores Reckitt’s compliance with UK listing and disclosure rules by making its full regulated information accessible in unedited form through official channels and its own site. For investors and other stakeholders, the availability of the 2025 Annual Report and AGM materials provides key information on the company’s performance and governance, and sets the timetable and venue for shareholder participation in corporate decision-making at the 2026 meeting.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6300.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Spark’s Take on RKT Stock

According to Spark, TipRanks’ AI Analyst, RKT is a Neutral.

The score is driven primarily by improved financial performance (notably profitability and lower leverage) and supportive valuation (moderate P/E and solid yield). These are tempered by weak technicals (below key moving averages with negative momentum) and earnings-call-flagged near-term pressures on cash flow, leverage, and 2026 margin/EPS visibility.

To see Spark’s full report on RKT stock, click here.

More about Reckitt

Reckitt Benckiser Group is a global consumer goods company focused on health, hygiene and home care products. Its portfolio includes well-known brands such as Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. The company aims to develop science-backed solutions that support healthier lives while pursuing broader sustainability and social impact goals.

Average Trading Volume: 2,158,390

Technical Sentiment Signal: Sell

Current Market Cap: £32.7B

For a thorough assessment of RKT stock, go to TipRanks’ Stock Analysis page.